Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1503802 · KPTIQ, KPTI

Karyopharm Therapeutics Inc.

Bankruptcy reported SEC-reporting company Newton, MA Nasdaq Late filing notice
An email when it files something new with the SEC. Your account

What this means

  • Bankruptcy or receivership reportedThe company reported a bankruptcy or receivership under Item 1.03 of Form 8-K on Nov 3, 2026. Creditors file claims with the bankruptcy court; the docket is on PACER.
  • Debt accelerated or in defaultOn Nov 3, 2026 the company reported an event that accelerates or increases a direct financial obligation (Item 2.04), for example a default under a loan or bond agreement.
  • Exchange listing at riskOn Nov 5, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Quarterly report lateOn Nov 13, 2026 the company filed Form NT 10-Q: it could not file its quarterly report on time. Rule 12b-25 gives an extra 15 calendar days for an annual report and 5 for a quarterly report. We have no later report from the company yet.
  • Stockholders’ deficitAt the end of 2025 total liabilities exceeded total assets: stockholders’ equity was −$293M (XBRL data filed with the SEC).
  • Net loss in 2025Net loss of $196M for the year (2024: −$76.4M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$146M$145M
Net income (loss)−$196M−$76.4M
Total assets$108M$164M
Total liabilities$401M$350M
Stockholders’ equity−$293M−$186M
Cash and equivalents$60.5M$62.5M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Karyopharm Therapeutics Inc.
CIK
0001503802
Tickers
KPTIQ, KPTI
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Bankruptcy reported
State of incorporation
Delaware
Business address
Newton, Massachusetts
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Jun 30, 2026
Bankruptcy reported
Yes (8-K Item 1.03)
Last edition event
Nov 13, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Nov 5, 2026 · filing
  • Debt accelerated or in default
    Form 8-K · items 1.01, 1.03, 2.03, 2.04, 7.01, 8.01, 9.01 · filed Nov 3, 2026 · filing · edition of Nov 3, 2026
  • Bankruptcy or receivership
    Form 8-K · items 1.01, 1.03, 2.03, 2.04, 7.01, 8.01, 9.01 · filed Nov 3, 2026 · filing · edition of Nov 3, 2026
  • Debt accelerated or in default
    Form 8-K · items 1.01, 2.04, 3.02, 8.01, 9.01 · filed Sep 11, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 13, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 13, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 17, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed May 28, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 14, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Feb 13, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 12, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01, 9.01 · filed Jan 12, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 3, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 3, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.02, 2.03, 3.02, 5.02, 7.01, 8.01, 9.01 · filed Oct 8, 2025 · filing
  • Results announced
    Form 8-K · items 1.01, 2.02, 2.03, 3.02, 5.02, 7.01, 8.01, 9.01 · filed Oct 8, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Sep 11, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 11, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 11, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed May 29, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 12, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 19, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Feb 19, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jan 31, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Jan 13, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jan 2, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Nov 20, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 5, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 5, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 17, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Aug 29, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 6, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 6, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed May 31, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 8, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 8, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 29, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Feb 29, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Jan 8, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Dec 12, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Dec 8, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 2, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 2, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Sep 1, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 2, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 2, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed May 25, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 4, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 4, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Feb 17, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 15, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Feb 15, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Jan 9, 2023 · filing